# Treatment Options for Chronic Respiratory Failure
Chronic respiratory failure requires a combination of supportive treatments aimed at improving oxygen supply, supporting breathing, and preventing complications. The approach varies considerably depending on the cause, severity, and stage of the disease. The main treatment groups are described below.
Oxygen therapy
In chronic respiratory failure, the goal is usually to maintain blood oxygen tension at a certain level so that tissues receive sufficient oxygen. This is achieved through various routes of administration.
**Home oxygen (using oxygen concentrators or cylinders)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Oxygen is administered via a nasal cannula or mask for long-term use at home. This slows disease progression and reduces cardiac arrhythmias in severe oxygen deficiency. Known side effects include local pressure on the nose and ears, and with prolonged use, dry mucous membranes. Patients must be regularly checked for the correct oxygen amount.
**High-flow Nasal Cannula (HFNC)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
This is a system that delivers warm, humidified oxygen-rich air through thin tubes in the nose at high flow rates. It is mainly used in hospital settings and helps with acute deterioration. It can reduce the risk of reintubation in patients with high reintubation risk. Side effects are rarely serious; local discomfort and dry mucous membranes can occur.
Non-invasive Ventilation
These are mask ventilations that support breathing without a tube in the trachea.
**CPAP (Continuous Positive Airway Pressure)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
CPAP applies the same air pressure throughout the entire breathing cycle, which helps keep the airways open. It is widely used for sleep apnea and certain forms of chronic failure. Side effects include headache, nasal congestion, and skin irritation around the mask.
**BiPAP or Noninvasive Ventilation (NIV)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
This system alternates between two pressures: a higher pressure during inhalation and lower during exhalation. It particularly helps patients whose bodies cannot exhale properly (such as in COPD). Support is adjusted to breathing needs. Side effects are similar to those of CPAP; prolonged use can cause skin damage.
**BPAP for Nighttime Use**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Dual-pressure systems during the night help maintain stable oxygen levels at night and reduce daytime fatigue. This is especially important in patients with central apnea episodes or significant oxygen deficiency at night.
Medication Treatment
**Bronchodilators (inhalers)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
These substances relax the muscles around the airways, allowing air to flow in and out more easily. They are inhaled and are mainly used in COPD or other obstructive lung diseases. Side effects include tremor of the hands, cardiac arrhythmias with excessive use, and oral thrush.
**Corticosteroids (inhalers or systemic)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
These anti-inflammatory agents reduce swelling in the airways and mucus production. Inhalers are used regularly in underlying chronic lung diseases. Systemic corticosteroids are given briefly during acute deterioration. Prolonged systemic use can cause bone loss, infections, and weight gain; therefore, they are prescribed carefully and for short periods.
**Diuretics**
ProveniIncluded in official guidelines, or approved by EMA or FDA
When the heart no longer pumps well and fluid accumulates (pulmonary edema), diuretics help the body shed excess fluid. This also helps breathing. Side effects include electrolyte imbalances and dehydration if not properly monitored.
**Pulmonary Vasodilators (for example, inhaled nitric oxide)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
In certain conditions with high pressure in the pulmonary vessels, these medications can relax blood vessels and relieve the heart. They are inhaled in hospital. Side effects are rare; headache and gastrointestinal complaints can occur.
Non-pharmacological Supportive Measures
**Physiotherapy and breathing exercises**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Targeted exercises improve breathing efficiency and enable patients to better manage their symptoms. Coughing and irritating cough can be better controlled by learning proper breathing techniques. This is safe and increases resilience.
**Weight management**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Overweight increases the workload on the respiratory system. Guidance toward healthy weight (under supervision of a dietitian and doctor) can reduce breathing difficulty and improve efficiency.
**Fluid restriction**
ProveniIncluded in official guidelines, or approved by EMA or FDA
In heart failure or certain kidney disease, it is important not to take in too much fluid, so the heart does not have to work extra and lungs do not fill up. This is determined per patient.
**Oral hygiene and mouth care**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Good mouth care reduces infections of the mouth and throat, which can reach the lungs. This is important because infections can worsen breathing difficulty.
Intensive forms of ventilation
**Invasive mechanical ventilation (intubated ventilation)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
When the body can no longer breathe on its own, a tube is inserted into the airway and connected to a ventilator. This delivers oxygen directly into the lungs and supports or fully replaces natural breathing. This usually happens in a hospital setting. Side effects include infections, damage to the vocal cords, and psychological consequences of being unable to speak.
**Long-term tracheostomy (permanent opening in the airway)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients who need long-term ventilation, a small opening in the airway (tracheostomy) can be made. This makes ventilation easier and safer than through the mouth, and allows patients more freedom. Tracheostomy care requires special attention against infections.
Treatment of the underlying cause
**COPD management**
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients with COPD as the cause, treatment focuses on smoking cessation, use of bronchodilators, and treatment of infections. This can slow progression and prevent exacerbations.
**Heart disease management**
ProveniIncluded in official guidelines, or approved by EMA or FDA
In heart failure as the cause, the heart is supported with medicines that improve pumping and reduce workload. ACE inhibitors, beta blockers and diuretics are standard.
**Neuromuscular disorders**
ProveniIncluded in official guidelines, or approved by EMA or FDA
In conditions such as ALS or myasthenia gravis, treatments focus on symptom management and prevention of complications. For certain conditions, specific medications exist that can slow progression.
Monitoring and supportive care
**Blood gas analysis and pulse oximetry**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular measurement of oxygen and carbon dioxide levels in the blood helps adjust treatment. At home, simple saturation meters can be used.
**Imaging (chest X-ray, CT)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular imaging helps detect complications such as infections or fluid accumulation early. This leads to faster intervention.
**Palliative care**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Despite treatment, chronic respiratory failure can be severe. Palliative care focuses on relieving feelings of suffocation, anxiety and pain. This is not aimed at cure, but at comfort and quality of life. Collaboration between pulmonologist, cardiologist, psychologist and nurses is important.
**Psychological support**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Chronic breathing difficulty is often accompanied by anxiety, depression and panic. Psychological help enables patients and relatives to cope with this and can significantly improve quality of life.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._